ARHGEF18
Basic information
Region (hg38): 19:7348937-7472485
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa 78 (Strong), mode of inheritance: AR
- retinitis pigmentosa (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinitis pigmentosa 78 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 28132693 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (17 variants)
- Retinitis pigmentosa 78 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGEF18 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 243 | 18 | 265 | |||
missense | 351 | 10 | 11 | 373 | ||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 7 | |||||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 23 | 28 | 7 | 58 | ||
non coding | 54 | 129 | 20 | 206 | ||
Total | 17 | 2 | 419 | 382 | 49 |
Highest pathogenic variant AF is 0.0000460
Variants in ARHGEF18
This is a list of pathogenic ClinVar variants found in the ARHGEF18 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-7372830-C-T | Uncertain significance (Aug 01, 2023) | |||
19-7376751-G-C | Benign (Aug 01, 2024) | |||
19-7378435-G-A | Uncertain significance (Jul 01, 2023) | |||
19-7379147-G-T | Uncertain significance (May 27, 2022) | |||
19-7383172-C-T | Likely benign (Feb 01, 2024) | |||
19-7439953-G-A | Uncertain significance (Oct 25, 2022) | |||
19-7439953-G-T | Uncertain significance (Sep 21, 2021) | |||
19-7439966-TG-T | Pathogenic (Mar 19, 2022) | |||
19-7439984-C-A | Uncertain significance (Mar 04, 2022) | |||
19-7439985-T-A | Benign (Jan 26, 2024) | |||
19-7439991-C-A | Likely benign (Jul 01, 2022) | |||
19-7439992-A-G | Uncertain significance (Aug 26, 2021) | |||
19-7439994-T-C | Likely benign (Apr 21, 2020) | |||
19-7440011-C-T | Uncertain significance (Aug 09, 2022) | |||
19-7440018-G-C | Likely benign (Jan 26, 2024) | |||
19-7440025-A-G | Uncertain significance (Mar 27, 2020) | |||
19-7440035-C-T | Uncertain significance (Jun 23, 2020) | |||
19-7440039-G-A | Likely benign (Jul 10, 2023) | |||
19-7440039-G-C | Likely benign (Feb 15, 2021) | |||
19-7440040-AGGCATAAAAAC-A | Pathogenic (Jun 20, 2022) | |||
19-7440046-A-T | Pathogenic (Jan 12, 2024) | |||
19-7440049-A-C | Inborn genetic diseases | Uncertain significance (Jan 25, 2023) | ||
19-7440059-C-T | Uncertain significance (Jul 05, 2022) | |||
19-7440063-G-C | Inborn genetic diseases | Uncertain significance (Aug 22, 2023) | ||
19-7440071-C-G | ARHGEF18-related disorder | Likely benign (Jan 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARHGEF18 | protein_coding | protein_coding | ENST00000359920 | 19 | 77365 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00177 | 0.998 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.25 | 568 | 740 | 0.767 | 0.0000516 | 7544 |
Missense in Polyphen | 175 | 249.76 | 0.70068 | 2556 | ||
Synonymous | 0.643 | 319 | 334 | 0.955 | 0.0000259 | 2378 |
Loss of Function | 4.65 | 15 | 50.8 | 0.296 | 0.00000243 | 585 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000854 | 0.000763 |
Ashkenazi Jewish | 0.000215 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000103 | 0.0000924 |
European (Non-Finnish) | 0.000173 | 0.000167 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000134 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPases. Its activation induces formation of actin stress fibers. Also acts as a GEF for RAC1, inducing production of reactive oxygen species (ROS). Does not act as a GEF for CDC42. The G protein beta-gamma (Gbetagamma) subunits of heterotrimeric G proteins act as activators, explaining the integrated effects of LPA and other G-protein coupled receptor agonists on actin stress fiber formation, cell shape change and ROS production. Required for EPB41L4B-mediated regulation of the circumferential actomyosin belt in epithelial cells (PubMed:22006950). {ECO:0000269|PubMed:11085924, ECO:0000269|PubMed:14512443, ECO:0000269|PubMed:15558029, ECO:0000269|PubMed:22006950, ECO:0000269|PubMed:28132693}.;
- Pathway
- Tight junction - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases;NRAGE signals death through JNK;Death Receptor Signalling;p75 NTR receptor-mediated signalling;G alpha (12/13) signalling events;Signaling by TGF-beta Receptor Complex;Signaling by TGF-beta family members;GPCR downstream signalling;Cell death signalling via NRAGE, NRIF and NADE;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Regulation of RhoA activity
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.409
- rvis_EVS
- 0.66
- rvis_percentile_EVS
- 84.19
Haploinsufficiency Scores
- pHI
- 0.109
- hipred
- N
- hipred_score
- 0.332
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.844
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arhgef18
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- arhgef18b
- Affected structure
- otolith
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- transforming growth factor beta receptor signaling pathway;G protein-coupled receptor signaling pathway;small GTPase mediated signal transduction;regulation of cell shape;actin cytoskeleton organization;regulation of Rho protein signal transduction;positive regulation of apoptotic process;regulation of small GTPase mediated signal transduction
- Cellular component
- cytosol;cytoskeleton;plasma membrane;apical plasma membrane;cell junction;apical part of cell;extracellular exosome
- Molecular function
- nucleic acid binding;guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity;metal ion binding